These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21356232)

  • 1. ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD.
    Gehricke JG; Hong N; Wigal TL; Chan V; Doan A
    Pharmacol Biochem Behav; 2011 May; 98(3):485-91. PubMed ID: 21356232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.
    Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K
    Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abstinence-induced withdrawal severity among adolescent smokers with and without ADHD: disentangling effects of nicotine and smoking reinstatement.
    Bidwell LC; Balestrieri SG; Colby SM; Knopik VS; Tidey JW
    Psychopharmacology (Berl); 2018 Jan; 235(1):169-178. PubMed ID: 29018894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
    Covey LS; Hu MC; Winhusen T; Weissman J; Berlin I; Nunes EV
    Drug Alcohol Depend; 2010 Jul; 110(1-2):156-9. PubMed ID: 20219292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.
    Hurt RD; Ebbert JO; Croghan IT; Schroeder DR; Sood A; Hays JT
    J Negat Results Biomed; 2011 Jan; 10():1. PubMed ID: 21276244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.
    Kollins SH; English JS; Roley ME; O'Brien B; Blair J; Lane SD; McClernon FJ
    Psychopharmacology (Berl); 2013 May; 227(1):19-30. PubMed ID: 23247366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.
    McClernon FJ; Kollins SH; Lutz AM; Fitzgerald DP; Murray DW; Redman C; Rose JE
    Psychopharmacology (Berl); 2008 Mar; 197(1):95-105. PubMed ID: 18038223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.
    Sweitzer MM; Kollins SH; Kozink RV; Hallyburton M; English J; Addicott MA; Oliver JA; McClernon FJ
    Neuropsychopharmacology; 2018 Mar; 43(4):851-858. PubMed ID: 29052617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.
    Berlin I; Hu MC; Covey LS; Winhusen T
    Drug Alcohol Depend; 2012 Aug; 124(3):268-73. PubMed ID: 22364776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.
    Liebrenz M; Fisher CE; Nellen R; Frei A; Biechl AC; Hiestand N; Huber A; Buadze A; Eich D
    BMC Psychiatry; 2016 Jul; 16():208. PubMed ID: 27377376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.
    McClernon FJ; Van Voorhees EE; English J; Hallyburton M; Holdaway A; Kollins SH
    Nicotine Tob Res; 2011 Sep; 13(9):784-92. PubMed ID: 21571687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of attention-deficit hyperactivity disorder symptom dimensions with smoking deprivation effects in adult smokers.
    Bidwell LC; Ameringer KJ; Leventhal AM
    Psychol Addict Behav; 2014 Mar; 28(1):182-92. PubMed ID: 24731115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
    Winhusen TM; Somoza EC; Brigham GS; Liu DS; Green CA; Covey LS; Croghan IT; Adler LA; Weiss RD; Leimberger JD; Lewis DF; Dorer EM
    J Clin Psychiatry; 2010 Dec; 71(12):1680-8. PubMed ID: 20492837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
    Gehricke JG; Hong N; Whalen CK; Steinhoff K; Wigal TL
    Psychol Addict Behav; 2009 Dec; 23(4):644-55. PubMed ID: 20025370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers.
    Gray KM; Baker NL; Carpenter MJ; Lewis AL; Upadhyaya HP
    Am J Addict; 2010; 19(4):325-31. PubMed ID: 20653639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
    Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C
    J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology.
    Pomerleau CS; Downey KK; Snedecor SM; Mehringer AM; Marks JL; Pomerleau OF
    Addict Behav; 2003 Aug; 28(6):1149-57. PubMed ID: 12834657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary cotinine levels in human tobacco smokers predict the attentional validity effect size during smoking abstinence.
    Shirtcliff EA; Marrocco RT
    Psychopharmacology (Berl); 2003 Feb; 166(1):11-8. PubMed ID: 12491028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.